A new therapeutic, DISC-0974, demonstrates significant selectivity for HFE2, a crucial regulator participating with human morphogenesis. Early results reveal that neutralizing RGMC/HFE2 function with this therapeutic https://www.targetmol.com/compound/disc_0974